The pharmacological treatment of dyslipidemia

C. A. Dujovne; W. S. Harris

doi:10.1146/annurev.pa.29.040189.001405

The pharmacological treatment of dyslipidemia

C. A. Dujovne, W. S. Harris

Research output: Contribution to journal › Review article › peer-review

17 Scopus citations

Abstract

This review discusses the drugs and other substances used to treat abnormal blood lipid levels (dyslipidemia) in order to retard arteriosclerosis. The relationship between dyslipidemia and morbidity and/or mortality from arteriosclerotic cardiovascular disease (ASCVD) has long been established.

Original language	English (US)
Pages (from-to)	265-288
Number of pages	24
Journal	Annual Review of Pharmacology and Toxicology
Volume	29
DOIs	https://doi.org/10.1146/annurev.pa.29.040189.001405
State	Published - 1989
Externally published	Yes

ASJC Scopus subject areas

Toxicology
Pharmacology

Access to Document

10.1146/annurev.pa.29.040189.001405

Cite this

@article{0f17b45cd2554d19a5c6adc01279c2d6,

title = "The pharmacological treatment of dyslipidemia",

abstract = "This review discusses the drugs and other substances used to treat abnormal blood lipid levels (dyslipidemia) in order to retard arteriosclerosis. The relationship between dyslipidemia and morbidity and/or mortality from arteriosclerotic cardiovascular disease (ASCVD) has long been established.",

author = "Dujovne, {C. A.} and Harris, {W. S.}",

year = "1989",

doi = "10.1146/annurev.pa.29.040189.001405",

language = "English (US)",

volume = "29",

pages = "265--288",

journal = "Annual Review of Pharmacology and Toxicology",

issn = "0066-4251",

publisher = "Annual Reviews Inc.",

}

TY - JOUR

T1 - The pharmacological treatment of dyslipidemia

AU - Dujovne, C. A.

AU - Harris, W. S.

PY - 1989

Y1 - 1989

N2 - This review discusses the drugs and other substances used to treat abnormal blood lipid levels (dyslipidemia) in order to retard arteriosclerosis. The relationship between dyslipidemia and morbidity and/or mortality from arteriosclerotic cardiovascular disease (ASCVD) has long been established.

AB - This review discusses the drugs and other substances used to treat abnormal blood lipid levels (dyslipidemia) in order to retard arteriosclerosis. The relationship between dyslipidemia and morbidity and/or mortality from arteriosclerotic cardiovascular disease (ASCVD) has long been established.

UR - http://www.scopus.com/inward/record.url?scp=0024506065&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024506065&partnerID=8YFLogxK

U2 - 10.1146/annurev.pa.29.040189.001405

DO - 10.1146/annurev.pa.29.040189.001405

M3 - Review article

C2 - 2658772

AN - SCOPUS:0024506065

SN - 0066-4251

VL - 29

SP - 265

EP - 288

JO - Annual Review of Pharmacology and Toxicology

JF - Annual Review of Pharmacology and Toxicology

ER -

The pharmacological treatment of dyslipidemia

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this